HFA Premium Access

No harmful effect of diuretic down-titration on pulmonary congestion when introducing sodium-glucose cotransporter 2 inhibitors

Congress Session

About the speaker

Doctor Mar Domingo

University Hospital Germans Trias and Pujol de Badalona, Badalona (Spain)
0 follower

34 more presentations in this session

Prospective evaluation of left heart echocardiographic parameters of the EMPAG-HF patient cohort(effects of empagliflozin on diuresis and renal function in patients with acute decompensated HF)

Speaker: Mr J. Bogoviku (Jena, DE)


Pharmacological inhibition of Hippo pathway with XMU-MP-1 does not improve outcomes in mice with autoimmune myocarditis.

Speaker: Doctor M. Nieto (Valladolid, ES)


T cell and antibody response following double dose of BNT162b2 mRNA Vaccine in heart transplant recipients

Speaker: Doctor M. Vanderheyden (Aalst, BE)


Device-detected sleep-disordered breathing predicts implantable defibrillator therapy in patients with heart failure.

Speaker: Doctor A. Mazza (Orvieto, IT)


A preliminary evaluation of a novel lifestyle intervention in patients with hypertrophic cardiomyopathy

Speaker: Miss A. Fuller (Newcastle-Upon-Tyne, GB)


Access the full session

Heart Failure ePosters - focus on Chronic Heart Failure 6

Speakers: Doctor M. Domingo, Mr J. Bogoviku, Doctor M. Nieto, Doctor M. Vanderheyden, Doctor A. Mazza...

About the event


Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Related content

ESC Premium Access

Hot off the press: latest updates on new therapeutic approaches to HFrEF – discussion.

29 August 2021

ESC Premium Access

New therapies for HFrEF: omecamtiv mecarbil.

29 August 2021

Open Access

Integrating EPA based therapy in the management of residual risk.

29 August 2021

This platform is supported by

logo Novo Nordisk